professor
Name
Jin-KI Kim
Address and Contact
55 Hanyangdaehak-ro, Sangnok-gu, Ansan, Gyeonggi-do 426-791, South Korea
Tel: +82-31-400-5808
E-mail: jinkikim@hanyang.ac.kr
Education
Ph. D. College of Pharmacy, Seoul National University, Republic of Korea (2005), Advisor: Chong-Kook Kim, Ph.D.
M.S. College of Pharmacy, Seoul National University, Republic of Korea (2000)
B.S. College of Pharmacy, Seoul National University, Republic of Korea (1998)
Research Experience
2011-present: Associate Professor, College of Pharmacy, Hanyang University
2010-2011: Postdoctoral Research Associate, Center for Nanotechnology in Drug Delivery, University of North Carolina at Chapel Hill
2007-2010: Postdoctoral Fellow, Department of Pharmaceutics, School of Pharmacy, University of MississippiResearch
2006-2007: Postdoctoral Fellow, Research Division for Applied Pharmceutical Life Sciences (Brain Korea 21 Project), Seoul National University
2005-2006: Postdoctoral Fellow, Research Institute of Pharmceutical Sciences, College of Pharmacy, Seoul National University
Jin-Ki Kim received his B.S in Pharmacy in 1998, and his Ph.d. in Physical Pharmacy (Pharmaceutics) from Seoul National University in 2005. He worked as a Senior Scientist at Research Institute of Pharmaceutical Sciensces, Seoul National University from 2005 to 2006 and at Research Division for Applied Pharmaceutical Life Sciences (Brain Korea 21 Project), Seoul National University. During the period 2007-2011, he worked in University of Mississippi and University of North Carolina at Chapel Hill as a Postdoctroal Fellow and Research Associate, respectively. He joined the faculty at College of Pharmacy, Hanyang University in 2011 where he teaches graduate student courses in Nanomedicine and Disperse System, and Pharmaceutics and Drug Delivery System for pharmacy student.
His current research interests are tissue-targeting drug delivery system, solubilization and enhancement of bioavailability of water-poorly solublel drugs, lipid-based nanoparticulate system, theranostic nanoparticies for anticancer therapy, and bioresponsive drug delivery system. He has published more than 30 research articles including ACS Nano, Small, Molecular Pharmaceutics and Journal of Controlled Release, and several patents in drug delivery areas.